XM does not provide services to residents of the United States of America.

Remy Cointreau's shares rise as investors bet on recovery



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 3-Remy Cointreau's shares rise as investors bet on recovery</title></head><body>

Updates shares in paragraphs 1 & 9, CEO quotes in paragraph 6, adds investor comment in paragraphs 11-12

LONDON, June 6 (Reuters) -Remy Cointreau's RCOP.PA shares rose more than 6% on Thursday after the drinks company expressed confidence about future growth following a tough year where profits fell sharply.

The maker of Remy Martin cognac and Cointreau liquor faced difficulties throughout the year in the United States and China, which make up the vast majority of cognac sales.

A tough economy dragged in China while elevated inventories in the United States weighed as sales came down from a post-COVID boom.

The company said a recovery was anticipated only from the second half, but it signalled confidence in future growth.

Progress towards its long-term targets, including high single-digit annual sales growth, will resume from 2025-26, it said.

Chief Executive Officer Eric Vallat said the company was taking a variety of measures to restore U.S. sales and the group's growth, and looking to build up sales elsewhere in the world including Europe, Nigeria, South Africa and India.

Remy's annual organic operating profit fell by 27.8% in the year ending March 31, but this was smaller than the 28.2% decline predicted by analysts.

The sharp profit fall came alongside a drop in sales, which were down 19.2% organically.

Remy's shares pared initial gains to stand 3.9% higher by 0842 GMT, but the stock remained among the top gainers in Europe's STOXX 600 index .STOXX and on track for their best day in a month.

The company's shares had hit their lowest since 2020 a day earlier, and closed down almost 30% on the start of the year.


U.S. TROUBLES

James Squire, a portfolio manager at Remy investor River Global, said the market was starting to buy into a Remy recovery after poor sentiment drove declines in the share price in recent months.

"The time to buy these stocks is when everyone else is worried," he continued, adding Remy's valuation would likely improve.

In the short-term, Remy continues to face difficulties in the United States.

The company said it had reduced staff in its U.S. division by 10% alongside other measures to improve performance.

Vallat told journalists Remy would continue to resist cutting prices or discounting. But it would pursue an "optimisation" of pricing by U.S. state for its cheaper category of cognac, hardest hit by the decline, he said.

Remy's profit beat was helped by 145 million euros ($157.82 million) in cost savings, exceeding its target of 100 million euros.

Its board would propose a 2 euro per share dividend, Remy said.




Reporting by Emma Rumney; Editing by Janane Venkatraman, Michael Perry and Jane Merriman

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.